Precision Biosciences (DTIL) Net Income Growth (3y) (2021 - 2026)
Precision Biosciences (DTIL) Net Income Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 9.16% |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 38.43% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 13.80% |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -3.84% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 79.26% |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Precision Biosciences | 178.85 Mn | 150.56 Mn | - | 8.27% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.27% |
| Dec 31, 2025 | 49.89% |
| Sep 30, 2025 | -49.61% |
| Jun 30, 2025 | 14.81% |
| Mar 31, 2025 | 14.66% |
| Dec 31, 2024 | 8.13% |
| Sep 30, 2024 | -10.02% |
| Jun 30, 2024 | -7.31% |
| Mar 31, 2024 | 45.70% |
| Dec 31, 2023 | 51.02% |
| Sep 30, 2023 | 28.86% |
| Jun 30, 2023 | 36.81% |
| Mar 31, 2023 | 27.83% |
| Dec 31, 2022 | 24.33% |
| Sep 30, 2022 | 29.40% |
| Jun 30, 2022 | -11.13% |
| Mar 31, 2022 | -14.78% |
| Dec 31, 2021 | -24.30% |
| Sep 30, 2021 | -31.38% |
| Jun 30, 2021 | 54.01% |